| ²é¿´: 549 | »Ø¸´: 2 | ||
¾²¾²µÄÀáµÎͳæ (³õÈëÎÄ̳)
|
[ÇóÖú]
¹ØÓÚÁ½ÆªÓ¢ÎÄÎÄÕ£¬ÓÐûÓдóÉñÁ˽⣬Çë´Í½Ì£¡
|
|
¡°Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.¡± ¡°Elimination of Unfit Cells Maintains Tissue Health and Prolongs Lifespan." ²»ÊÇÀÁ¶è£¬ÊµÔÚÊÇʱ¼äÌ«¼±£¬×ż±Á˽⡣ϣÍûÓÐÁ˽âµÄ³é³öÒ»µãʱ¼äÖ¸µ¼Ò»Ï¡£ |
» ²ÂÄãϲ»¶
Wnt-C59£ºPORCN°ÐÏò»¯Ñ§Ì½Õ룬WntÐźÅͨ·×è¶Ï»úÖÆÓë¿ÆÑÐÓ¦ÓÃÈ«½âÎö
ÒѾÓÐ0È˻ظ´
Fexaramine£º³¦µÀÏÞÖÆÐÔFXR»¯Ñ§Ì½Õ룬½á¹¹ÌØÕ÷ÓëÐźÅͨ·Ñо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ152È˻ظ´
NVS-STG2£º°ÐÏòSTING¿çĤÓòµÄ·Ö×Ó½ºÀ༤¶¯¼Á£¬½á¹¹ÌØÕ÷Óë¹Ñ¾Û»¯»úÖÆÑо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
DOTA-GPC3ëÄ£¨CAS 3066439-94-6£©£ºË«¹¦ÄÜ·Ö×Ó̽ÕëǰÌåµÄ½á¹¹ÌØÕ÷Óë±ê¼ÇÓ¦ÓýâÎö
ÒѾÓÐ0È˻ظ´
¿ÆÑÐÓà TLR7/8 Ë«¼¤¶¯¼ÁÔõôѡ£¿ÏÖ»õÓëÖÊ¿ØÒªµã
ÒѾÓÐ0È˻ظ´
SEL120-34A HCl£ºCDK8/CDK19¸ßÑ¡ÔñÐÔ¼¤Ã¸ÒÖÖÆ¼Á
ÒѾÓÐ0È˻ظ´
ÇâÑõ»¯¼Ø»î»¯²Ù×÷
ÒѾÓÐ18È˻ظ´
É¢½ð
ÒѾÓÐ68È˻ظ´
ÉúÎïÖʳ¬¼¶µçÈÝÆ÷
ÒѾÓÐ0È˻ظ´
gaoyang636
ľ³æ (ÖøÃûдÊÖ)
- MolEPI: 5
- Ó¦Öú: 202 (´óѧÉú)
- ½ð±Ò: 4111.4
- É¢½ð: 7
- ºì»¨: 14
- Ìû×Ó: 1108
- ÔÚÏß: 159.8Сʱ
- ³æºÅ: 384065
- ×¢²á: 2007-05-27
- רҵ: »ùÒò×éѧ
2Â¥2016-03-22 14:09:46
¾²¾²µÄÀáµÎ
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 72.3
- É¢½ð: 5
- Ìû×Ó: 42
- ÔÚÏß: 12.5Сʱ
- ³æºÅ: 1126205
- ×¢²á: 2010-10-19
- רҵ: »·¾³Î¢ÉúÎïѧ
3Â¥2016-04-28 17:34:40









»Ø¸´´ËÂ¥